Research from The Kirby Institute released for World Hepatitis Day shows Australia could be one of the first countries in the world to eliminate hepatitis C.
The newer drugs for hepatitis C might mean fewer people are diagnosed with liver cancer, write Maryam Alavi and Greg Dore.
More Australians have been treated for hepatitis C in the past 12 months than the last decade combined, following the listing of a new generation therapy on the Pharmaceutical Benefits Scheme.
A UNSW research trial to examine if e-cigarettes can help smokers quit and a world-first treatment for teenagers with PTSD and substance abuse are among projects to receive major backing in the latest NHMRC funding round.
New hepatitis C treatments are expensive but Greg Dore and Marianne Martinello argue that facilitating global access to safe, direct-acting antivirals will herald a revolution.
Australian researchers are leading the world in the battle to eliminate hepatitis C.
An Indigenous hepatitis project in Western Sydney could be expanded across NSW, thanks to input from UNSW health researchers.
Australian funding of new hepatitis C treatments has provided the therapeutic tools to eliminate the disease as a public health issue within a decade, writes Greg Dore.
Australia is on track to eliminate hepatitis C if record numbers of people living with the virus continue to seek and receive breakthrough antiviral treatment, according to a new analysis.
The Kirby Institute at UNSW has welcomed a $1.4 million gift from the late Dr Lynn Joseph that will help transform the lives of Australians living with hepatitis C.